INSTITUTION CLINICAL TRIAL AGREEMENT SMLOUVA SE ZDRAVOTNICKÝM ZAŘÍZENÍM O PROVEDENÍ KLINICKÉHO HODNOCENÍInstitution Clinical Trial Agreement • February 28th, 2019
Contract Type FiledFebruary 28th, 2019This Institution Clinical Trial Agreement (“Agreement”) effective as of the last date of signature (“Effective Date”) by and among: Covance Inc, a corporation of the State of Delaware, having its principal place of business 206 Carnegie Center, Princeton, New Jersey 08450, USA, and its affiliates (hereinafter referred to as “Covance”); and Oblastní nemocnice Kolín, a.s., nemocnice Středočeského kraje, Žižkova 146, 280 02 Kolín, Česká republika represented by Petre Chudomel, MD, MBA, chairmen of the Board and Igor Karen, MD, vice-chairmen of the Board, (hereinafter referred to as “Institution”) Whereas, Covance and Institution are hereinafter referred to individually as “Party” and collectively as “Parties”; Whereas, Covance is acting in its capacity as a contract research organization as defined in ICH-GCP 1.20 as an independent contractor of OMEICOS Therapeutics GmbH having its principal offices at Robert-Rössle-Straße 10 (Building 79), 13125 Berlin, Germany (“Sponsor”) to a